Switch theme
Sign up to access all valuation multiples
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
2011
202
LTM Revenue $29.2M
LTM EBITDA -$26.3M
$33.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
DarioHealth has a last 12-month revenue (LTM) of $29.2M and a last 12-month EBITDA of -$26.3M.
In the most recent fiscal year, DarioHealth achieved revenue of $27.0M and an EBITDA of -$50.3M.
DarioHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See DarioHealth valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $29.2M | XXX | $27.0M | XXX | XXX | XXX |
| Gross Profit | $18.0M | XXX | $13.3M | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | -$26.3M | XXX | -$50.3M | XXX | XXX | XXX |
| EBITDA Margin | -90% | XXX | -186% | XXX | XXX | XXX |
| EBIT | -$26.0M | XXX | -$57.7M | XXX | XXX | XXX |
| EBIT Margin | -89% | XXX | -214% | XXX | XXX | XXX |
| Net Profit | -$41.4M | XXX | -$42.7M | XXX | XXX | XXX |
| Net Margin | -142% | XXX | -158% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, DarioHealth's stock price is $1.
DarioHealth has current market cap of $31.4M, and EV of $33.9M.
See DarioHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $33.9M | $31.4M | XXX | XXX | XXX | XXX | $-0.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, DarioHealth has market cap of $31.4M and EV of $33.9M.
DarioHealth's trades at 1.3x EV/Revenue multiple, and -0.7x EV/EBITDA.
Equity research analysts estimate DarioHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DarioHealth has a P/E ratio of -0.8x.
See valuation multiples for DarioHealth and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $31.4M | XXX | $31.4M | XXX | XXX | XXX |
| EV (current) | $33.9M | XXX | $33.9M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | -1.3x | XXX | -0.7x | XXX | XXX | XXX |
| EV/EBIT | -1.3x | XXX | -0.6x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -0.8x | XXX | -0.7x | XXX | XXX | XXX |
| EV/FCF | -1.0x | XXX | -0.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDarioHealth's last 12 month revenue growth is 28%
DarioHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
DarioHealth's rule of 40 is -239% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DarioHealth's rule of X is -20% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for DarioHealth and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | -90% | XXX | -186% | XXX | XXX | XXX |
| EBITDA Growth | -53% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -239% | XXX | -158% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -20% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 97% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 89% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 263% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedAdvisor | XXX | XXX | XXX | XXX | XXX | XXX |
| Oneview Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Brain+ | XXX | XXX | XXX | XXX | XXX | XXX |
| Sphere | XXX | XXX | XXX | XXX | XXX | XXX |
| Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DarioHealth acquired XXX companies to date.
Last acquisition by DarioHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . DarioHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was DarioHealth founded? | DarioHealth was founded in 2011. |
| Where is DarioHealth headquartered? | DarioHealth is headquartered in United States of America. |
| How many employees does DarioHealth have? | As of today, DarioHealth has 202 employees. |
| Who is the CEO of DarioHealth? | DarioHealth's CEO is Mr. Erez Raphael. |
| Is DarioHealth publicy listed? | Yes, DarioHealth is a public company listed on NAS. |
| What is the stock symbol of DarioHealth? | DarioHealth trades under DRIO ticker. |
| When did DarioHealth go public? | DarioHealth went public in 2013. |
| Who are competitors of DarioHealth? | Similar companies to DarioHealth include e.g. MedAdvisor, Oneview Healthcare, Brain+, Sphere. |
| What is the current market cap of DarioHealth? | DarioHealth's current market cap is $31.4M |
| What is the current revenue of DarioHealth? | DarioHealth's last 12 months revenue is $29.2M. |
| What is the current revenue growth of DarioHealth? | DarioHealth revenue growth (NTM/LTM) is 28%. |
| What is the current EV/Revenue multiple of DarioHealth? | Current revenue multiple of DarioHealth is 1.2x. |
| Is DarioHealth profitable? | Yes, DarioHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of DarioHealth? | DarioHealth's last 12 months EBITDA is -$26.3M. |
| What is DarioHealth's EBITDA margin? | DarioHealth's last 12 months EBITDA margin is -90%. |
| What is the current EV/EBITDA multiple of DarioHealth? | Current EBITDA multiple of DarioHealth is -1.3x. |
| What is the current FCF of DarioHealth? | DarioHealth's last 12 months FCF is -$35.1M. |
| What is DarioHealth's FCF margin? | DarioHealth's last 12 months FCF margin is -121%. |
| What is the current EV/FCF multiple of DarioHealth? | Current FCF multiple of DarioHealth is -1.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
